top of page
Asthra Logo_Purple horizontal.png

White Papers

How GenAI is taking CSR timelines from three months to less than 10 days

Manual Clinical Study Report (CSR) authoring is time-consuming, costly, and prone to errors. Any delays in creating a first draft directly impact regulatory submission timelines, which in turn delay time-to-market.

Fully traceable Module 3 first drafts in hours with Asthra

Traditional CMC authoring is often thousands of pages long, built with critical data from development, manufacturing, QC and supply chain systems.As the primary source of evidence for a drug, accurate and traceable drafts are a non-negotiable.

bottom of page